Manipulation of the mouse germline in the study of Min-induced neoplasia

Seminars in Cancer Biology

Volumn 7, Issue 5, 1996, Pages 249-260

  Bilger, Andrea ^b   Shoemaker, Alex R ^a,b   Gould, Karen A ^a,b   Dove, William F ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Apc; Intestinal; Min; Mom1; Tumorigenesis

Indexed keywords

DNA; DNA METHYLTRANSFERASE; PROTEIN P53;

ANIMAL MODEL; BASE MISPAIRING; CANCER GENETICS; CANCER MODEL; CARCINOGENESIS; COLON POLYPOSIS; DNA METHYLATION; DNA MODIFICATION; DNA REPAIR; GENE MUTATION; GERM LINE; INTESTINE; INTESTINE CANCER; MAMMARY GLAND; MOUSE; MOUSE MUTANT; NONHUMAN; PANCREAS; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0030265301     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.1996.0033     Document Type: Review

References (117)

1. 1. Moser AR, Pitot HC, Dove WF (1990) A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247:322-324
2. 2. Russell WL, Kelly EM, Hunsicker PR, Bangham JW, Maddux SC, Phipps EL (1979) Specific-locus test shows ethylnitrosourea to be the most potent mutagen in the mouse. Proc Natl Acad Sci USA 76:5818-5819
3. 3. Su LK, Kinzler KW, Vogelstein B, Preisinger AC, Moser AR, Luongo C, Gould KA, Dove WF (1992) Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256:668-670
4. 4. Cordes SP, Barsh GS (1994) The mouse segmentation gene kr encodes a novel basic domain-leucine zipper transcription factor. Cell 79:1025-1034
5. 5. Zingg BC, Pretsch W, Mohrenweiser HW (1995) Molecular analysis of four ENU induced triosephosphate isomerase null mutants in Mus musculus. Mutat Res 328:163-173
6. 6. Hitotsumachi S, Carpenter DA, Russell WL (1985) Dose-repetition increases the mutagenic effectiveness of N-ethyl-N-nitrosourea in mouse spermatogonia. Proc Natl Acad Sci, USA 82:6619-6621
7. 7. McDonald JD, Bode VC, Dove WF, Shedlovsky A (1990) Pahhph-5: a mouse mutant deficient in phenylalanine hydroxylase. Proc Natl Acad Sci, USA 87:1965-1967
8. 8. Shedlovsky A, Guenet J-L, Johnson LL, Dove WF (1986) Induction of recessive lethal mutations in the T/ t-H-2 region of the mouse genome by a point mutagen. Genet Res Camb 47:135-142
9. 9. Shedlovsky A, King TR, Dove WF (1988) Saturation germ line mutagenesis of the murine t region including a lethal allele at the quaking locus. Proc Natl Acad Sci, USA 85:180-184
10. 10. Bulow S (1987) Familial polyposis coli. Dan Med Bull 34:1-15
11. 11. Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, Joslyn G, Stevens J, Spirio L, Robertson M, Sargeant L, Krapcho K, Wolff E, Burt R, Hughes JP, Warrington J, McPherson J, Wasmuth J, Le Paslier D, Adberrahim H, Cohen D, Leppert M, White R (1991) Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66:589-600
12. 12. Nishisho I, Nakamura Y, Miyoshi Y, Miki Y, Ando H, Horii A, Koyama K, Utsunomiya J, Baba S, Hedge P, Markham A, Krush A, Petersen G, Hamilton SR, Nilbert MC, Levy DB, Bryan TM, Preisinger AC, Smith KJ, Su LK, Kinzler KW, Vogelstein B (1991) Mutation of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253:665-668
13. 13. Polakis P (1995) Mutations in the APC gene and their implications for protein structure and function. Curr Opin Genet Dev 5:66-71
14. 14. Miyaki M, Konishi M, Kikuchi-Yanoshita R, Enomoto M, Igari T, Tanaka K, Muraoka M, Takahashi H, Amada Y, Fukayama M, Maeda Y, Iwama T, Mishima Y, Mori T, Koike M (1994) Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors. Cancer Res 54:3011-3020
15. 15. Merritt AJ, Potten CS, Kemp CJ, Hickman JA, Balmain A, Lane DP, Hall PA (1994) The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice. Cancer Res 54:614-617
16. 16. Nordling CO (1953) A new theory on the cancer-inducing mechanism. Br J Cancer 7:68-72
17. 17. Armitage P, Doll R (1954) The age distribution of cancer and a multi-stage theory of carcinogenesis. Br J Cancer 8:1-12
18. 18. Ashley DJB (1969) The two 'hit' and multiple 'hit' theories of carcinogenesis. Br J Cancer 213:313-328
19. 19. Gotley DC, Reeder JA, Fawcett J, Walsh MD, Bates P, Simmons DL, Antalis TM (1996) The deleted in colon cancer (DCC) gene is consistently expressed in colorectal cancers and metastases. Oncogene 13:787-795
20. 20. Coffey RJ, McCutchen CM, Graves-Deal R, Polk WH (1992) Transforming growth factors and related peptides in gastronintestinal neoplasia. J Cell Biochem 16G:111-118
21. 21. Derynck R, Goeddel DV, Ullrich A, Gutterman JU, Williams RD, Bringham TS (1996) Synthesis of messenger RNAs for transforming growth factors a and band the epidermal growth factor receptor by human tumors. Cancer Res 47:707-712
22. 22. Ciardiello F, Kim N, Saeki T, Dono R, Persico MG, Plowman GD, Garrigues J, Radke S, Todaro GJ, Salomon DS (1991) Differential expression of epidermal growth factor-related proteins in human colorectal tumors. Proc Natl Acad Sci USA 88:7792-7796
23. 23. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61:759-767
24. 24. Sano H, Sawahito Y, Wilder RL, Hashiramoto A, Mukai S, Asai K, Kimura S, Kato H, Kondo M, H1a T (1995) Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 55:3785-3789
25. 25. Dorui S, Sheffield JP, Poulsom R, Northover JMA, Hart IR (1993) E-cadherin expression in colorectal cancer. Am J Pathol 142:981-986
26. 26. Kinzler KW, Nilbert MC, Su L-K, Vogelstein B, Bryan TM, Levy DB, Smith KJ, Preisinger AC, Hedge P, McKechnie D, Finniear R, Markham A, Groffen J, Boguski MS, Altschul SF, Horii A, Ando H, Miyoshi Y, Miki Y, Nishisho I, Nakamura Y (1991). Identification of FAP locus genes from chromosome 5q21. Science 253:661-665
27. 27. Su L-K, Burrell M, Hill DE, Gyuris J, Brent R, Wiltshire R, Trent J, Vogelstein B, Kinzler KW (1995) APC binds to the novel protein EB1. Cancer Res 55:2972-2977
28. 28. Joslyn G, Richardson DS, White R, Alber T (1993) Dimer formation by an N-coiled coil in the APC protein. Proc Natl Acad Sci USA 90:11109-11113
29. 29. Matsumine A, Ogai A, Senda T, Okumura N, Satoh K, Baeg G-H, Kawahara T, Kobayashi S, Okada M, Toyoshima K, Akiyama T (1996) Binding of APC to the human homolog of the Drosophila discs large tumor suppressor protein. Science 272:1020-1023
30. 30. Munemitsu S, Souza B, Müller O, Albert I, Rubinfeld B, Polakis P (1994) The APC gene product associates with microtubules in vivo and promotes their assembly in vitro. Cancer Res 54:3676-3681
31. 31. Su LK, Vogelstein B, Kinzler KW (1993) Association of the APC tumor suppressor protein with catenins. Science 262:1734-1737
32. 32. Rubinfeld B, Souza B, Albert I, Müller O, Chamberlain S, Masiarz FR, Munemitsu S, Polakis P (1993) Association of the APC Gene Product with β-Catenin. Science 262:1731-1734
33. 33. Rubinfeld B, Souza B, Albert I, Munemitsu S, Polakis P (1995) The APC protein and E-cadherin form similar but independent complexes with a-catenin, b-catenin, and plakoglobin. J Biol Chem 270:5549-5555
34. 34. Munemitsu S, Albert I, Souza B, Rubinfeld B, Polakis P (1995) Regulation of intracellular β-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc Natl Acad Sci USA 92:3046-3050
35. 35. Nathke IS, Adams CL, Polakis P, Sellin J, Nelson WJ (1996) The adenomatous polyposis coli tumor suppressor protein localizes to plasma membrane sites involved in active cell migration. J Cell Biol 134:165-179
36. 36. Hoschuetzky H, Aberle H, Kemler R (1994) β-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor. J Cell Biol 127:1375-1380
37. 37. Noordemeer J, Klingensmith J, Perrimon N, Nusse R (1994) dishevelled and armadillo act in the wingless signalling pathway in Drosophila. Nature 367:80-83
38. 38. Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, Polakis P (1996) Binding of GSK3b to the APC-β-catenin complex and regulation of complex assembly. Science 272:1023-1026
39. 39. Hermiston ML, Wong MH, Gordon JI (1996) Forced expression of E-cadherin in the mouse intestinal epithelium slows cell migration and provides evidence for nonautonomous regulation of cell fate in a self-renewing system. Genes Dev 10:985-996
40. 40. Wong MH, Hermiston ML, Syder AJ, Gordon JI (1996) Forced expression of the tumor suppressor adenomatosis polyposis coli protein induces disordered cell migration in the intestinal epithelium. Proc Natl Acad Sci, USA 93:9588-9593
41. 41. Behrens J, von Kries JP, Kuhl M, Bruhn L, Wedlich D, Grosschedl R, Birchmeier W (1996) Functional interactions of β-catenin with the transcription factor LEF-1. Nature 382:638-642
42. 42. Shoemaker AR, Gould KA, Luongo C, Moser AR, Dove WF (1996) Studies of neoplasia in the Min mouse. Biochim Biophys Acta 1332:f25-f48
43. 43. Shoemaker AR, Moser AR, Dove WF (1995) N-ethyl-N-nitrosourea treatment of multiple intestinal neoplasia (Min) mice: age-related effects on the formation of intestinal adenomas, cystic crypts, and epidermoid cysts. Cancer Res 55:4479-4485
44. 44. Luongo C, Moser AR, Gledhill S, Dove WF (1994) Loss of Apc+ in intestinal adenomas from Min mice. Cancer Res 54:5947-5952
45. 45. Levy DB, Smith KJ, Beazer-Barclay Y, Hamilton SR, Vogelstein B, Kinzler KW (1994) Inactivation of both APC alleles in human and mouse tumors. Cancer Res 54:5953-5958
46. 46. Munemitsu S, Souza B, Müller O, Albert I, Rubinfeld B, Polakis P (1994) The APC gene product associates with microtubules in vivo and promotes their assembly in vitro. Cancer Res 54:3676-3681
47. 1 to S phase. EMBO 14:5618-5625
48. 48. Oshima M, Oshima H, Kobayashi M, Tsutsumi M, Taketo MM (1995) Evidence against dominant negative mechanisms of intestinal polyp formation by Apc gene mutations. Cancer Res 55:2719-2722
49. 49. Lindgen V, Bryke CR, Ozcelik T, Yang-Feng TL, Francke U (1992) Phenotypic cytogenic, and molecular studies of three patients with constitutional deletions of chromosome 5 in the region of the gene for familial adenomatous polyposis. Am J Hum Genet 50:988-997
50. 50. Hodgson SV, Coonar AS, Hanson PJV, Cottrell S, Scriven PN, Jones T, Hawley PR, Wilkinson ML (1992) Two cases of 5q deletions in patients with familial adenomatous polyposis: possible link with Caroli's disease. J Med Genet 30:369-375
51. 51. Moser AR, Shoemaker AR, Connelly CS, Clipson L, Gould KA, Luongo C, Dove WF, Siggers PH, Gardner RL (1995) Homozygosity for the Min allele of Apc results in disruption of mouse development prior to gastrulation. Dev Dynam 203:422-433
52. 52. Ezzell C (1996) Murine mania: researchers devise a host of new techniques for making knockout mice. J NIH Res 8:33-36
53. 53. Moser AR, Mattes EM, Dove WF, Lindstrom MJ, Haag JD, Gould MN (1993) ApcMin, a mutation in the murine Apc gene, predisposes to mammary carcinomas and focal alveolar hyperplasias. Proc Natl Acad Sci 90:8977-8981
54. 54. Paul P, Letteboer T, Gelbert L, Groden J, White R, Coppes MJ (1993) Identical APC exon 15 mutations result in a variable phenotype in familial adenomatous polyposis. Hum Mol Genet 2:925-931
55. 55. Leppert M, Burt R, Hughes JP, Samowitz W, Nakamura Y, Woodward S, Gardner E, Lalouel J-M, White R (1990) Genetic analysis of an inherited predisposition to colon cancer in a family with a variable number of adenomatous polyps. New Engl J Med 322:904-908
56. 56. Moser AR, Dove WF, Roth KA, Gordon JI (1992) The Min (multiple intestinal neoplasia) mutation: its effect on gut epithelial cell differentiation and interaction with a modifier system. J Cell Biol 116:1517-1526
57. 57. Dietrich WF, Lander ES, Smith JS, Moser AR, Gould KA, Luongo C, Borenstein N, Dove WF (1993) Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 75:631-639
58. 58. Gould KA, Luongo C, Moser AR, McNeley MK, Borenstein N, Shedlovsky A, Dove WF, Hong K, Dietrich WF, Lander ES (1996) Genetic evaluation of candidate genes for the Mom1 modifier of intestinal neoplasia in mice. Genetics 144:1769-1776
59. 59. Moser AR, Luongo C, Gould KA, McNeley MK, Shoemaker AR, Dove WF (1995) ApcMin: A mouse model for intestinal and mammary tumorigenesis. Eur J Cancer 31A:1061-1064
60. 60. Gould KA, Dietrich WF, Borenstein N, Lander ES, Dove WF (1996) Mom1 is a semi dominant modifier of intestinal adenoma size and multiplicity in Minl + mice. Genetics 144:1777-1785
61. 61. Lande R, Thompson R (1990) Efficiency of marker-assisted selection in the improvement of quantitative traits. Genetics 124:743-756
62. 62. Hillel J, Schaap T, Haberfeld A, Jeffreys AJ, Plotzky Y, Cahaner A, Lavi U (1990) DNA fingerprints applied to gene introgression in breeding programs. Genetics 124:783-789
63. 63. Hospital F, Chevalet C, Mulsant P (1992) Using markers in gene introgression breeding programs. Genetics 132:1199-1210
64. 64. Dove WF, Luongo C, Connelly CS, Gould KA, Shoemaker AR, Moser AR, Gardner RL (1994) The adenomatous polyposis coli gene of the mouse in development and neoplasia. Cold Spring Harbor Symp Quant Biol 59:501-508
65. 65. MacPhee M, Chepenik KP, Liddell RA, Nelson KK, Siracusa LD, Buchberg AM (1995) The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia. Cell 81:957-966
66. 66. Mulherkar R, Rao RS, Wagle AS, Patki V, Deo MG (1993) Enhancing factor, a paneth cell specific protein from mouse small intestines: predicted amino acid sequence from RT-PCR amplified cDNA and its expression. Biochem Biophys Res Commun 195:1254-1263
67. 67. Mulherkar R, Desai SJ, Rao RS, Wagle AS, Deo MG (1991) Expression of enhancing factor gene and its localization in mouse tissues. Histochemistry 96:367-370
68. 2 gene in inbred mouse strains. J Biol Chem 270:22378-22385
69. 69. Malo D, Vidal SM, Hu J, Skamene E, Gros P (1993) High-resolution linkage map in the vicinity of the host resistance locus Bcg. Genomics 16:655-663
70. 70. Malo D, Vidal S, Lieman JH, Ward DC, Gros P (1993) Physical delineation of the minimal chromosomal segment encompassing the murine host resistance locus Bcg. Genomics 17:667-675
71. 71. Vidal SM, Malo D, Vogan K, Skamene E, Gros P (1993) Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell 73:469-485
72. 72. Vidal S, Tremblay ML, Govoni G, Gauthier S, Sebastiani G, Malo D, Skamene E, Olivier M, Jothy S, Gros P (1995) The Ity/ Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nrampl gene. J Exp Med 182:655-666
73. 73. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamp A, Skolnick MH (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71
74. 2. Biochim Biophys Acta 1215:115-120
75. 2S containing 16 cysteines. J Biol Chem 269:23018-23024
76. 76. Tischfield JA, Xia Y-R, Shih DM, Klisak I, Chen J, Engle SJ, Siakotos AN, Winstead MV, Seilhamer JJ, Allamand V, Gyapay G, Lusis AJ (1996) Low-molecular-weight, calcium-dependent phospholipase A2 genes are linked and map to homologous chromosome regions in mouse and human. Genomics 32:328-333
77. 2 in transgenic mice results in epidermal hyperplasia in the absence of inflammatory infiltrate. J Clin Invest 97:2233-2241
78. 78. Sugarbaker JP, Gunderson LL, Wittes RW (1985) Colorectal cancer, in Cancer: Principles and Practices of Oncology, Second Ed. (De Vita VT, Hellman S, Rosenberg SA Eds) pp 795-816. J.B. Lippincott, Philadelphia
79. 79. Marnett LJ (1994) Generation of mutagens during arachidonic acid metabolism. Cancer Met Rev 13:303-308
80. 80. Thun MJ (1994) Aspirin, NSAIDs, and digestive tract cancers. Cancer Met Rev 12:269-277
81. 81. Giardiello FM (1994) Sulindac and polyp regression. Cancer Met Rev 13:279-283
82. 82. Boolbol SK, Dannenberg AJ, Chadburn A, Martucci C, Guo XJ, Ramonetti JT, Abreu-Goris M, Newmark HL, Lipkin ML, DeCosse JJ, Bertagnolli MM (1996) Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res 56:2556-2560
83. 83. Jacoby RF, Marshall DJ, Newton MA, Novakovic K, Tutsch K, Cole CE, Lubet RA, Kelloff GJ, Verma A, Moser AR, Dove WF (1996) Chemoprevention of spontaneous intestinal adenomas in the ApcMin mouse model by the nonsteroidal antiinflammatory drug piroxicam. Cancer Res 56:710-714
84. 84. Beazer-Barclay Y, Levy DB, Moser AR, Dove WF, Hamilton SR, Vogelstein B, Kinzler KW (1996) Sulindac suppresses tumorigenesis in the Min Mouse. Carcinogenesis
85. 85. Young MRI (1994) Eicosanoids and the immunology of cancer. Cancer Met Rev 13:337-348
86. 86. Herschman HR (1994) Regulation of prostaglandin synthase-1 and prostaglandin synthase-2. Cancer Met Rev 13:241-256
87. 2. J Clin Invest 95:603-610
88. 88. Gould KA, Dove WF (1996) Action of Min and Mom1 on neoplasia in ectopic intestinal grafts. Cell Growth Diff 7:1361-1368.
89. 89. Tomlinson IPM, Neale K, Talbot IC, Spigelman AD, Williams CB, Phillips RKS, Bodmer WF (1996) A modifying locus for familial adenomatous polyposis may be present on chromosome 1p35-p36. J Med Genet 33:268-273
90. 90. Spirio LN, Kutchera W, Win stead MV, Pearson B, Kaplan C, Robertson M, Lawrence E, Burt RW, Tischfield JA, Leppert MF, Prescott SM, White R (1996) Three secretory phospholipase A2 genes that map to human chromosome IP35-36 are not mutated in individuals with attenuated adenomatous polyposis coli. Cancer Res 56:955-958
91. 91. Bardi G, Sukhikh T, Pandis N, Fenger C, Kronborg O, Heim S (1996) Karyotypic characterization of colorectal adenocarci-nomas. Genes Chromosomes Cancer 12:97-109
92. 92. Riggins GJ, Markowitz S, Wilson JK, Vogelstein B, Kinzler KW (1995) Absence of secretory phospholipase A2 gene alterations in human colorectal cancer. Cancer Res 55:5184-5186
93. 93. Lee JM, Bernstein A (1995) Apoptosis, cancer and the p53 tumour suppressor gene. Cancer Met Rev 14:149-161
94. 94. Clarke AR, Cummings MC, Harrison DJ (1995) Interaction between murine germline mutations in p53 and APC predisposes to pancreatic neoplasia but not to increased intestinal malignancy. Oncogene 11:1913-1920
95. 95. Laird PW, Jackson-Grusby L, Fazeli A, Dickinson S, Jung WE, Li E, Weinberg RA, Jaenisch R (1995) Suppression of intestinal neoplasia by DNA hypomethylation. Cell 81:197-205
96. 96. Li E, Beard C, Jaenisch R (1993) Role for DNA methylation in genomic imprinting. Nature 366:362-365
97. 97. Marra G, Boland CR (1995) Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J Natl Cancer Inst 87:1114-1125
98. 98. Reitmar AH, Redston M, Cai JC, Chuang TCY, Bjerknes M, Cheng H, Hay K, Gallinger S, Bapat B, Mak TW (1996) Spontaneous intestinal carcinomas and skin neoplasms in Msh2-deficient mice. Cancer Res 56:3842-3849
99. 99. Reitmair AH, Cai J-C, Bjerknes M, Redston M, Cheng H, Pind MTL, Hay K, Mitri A, Bapat BV, Mak TW, Gallinger S (1996) MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis. Cancer Res 56:2922-2926
100. 100. Lazar V, Gradjouan S, Bognel C, Couturier D, Rougier P, Bellet D, Bressac-de Paillerets B (1994) Accumulation of multiple mutations in tumor suppressor genes during colorectal tumorigenesis in HNPCC patients. Hum Mol Genet 3:2257-2260
101. 101. Huang J, Papadopoulos N, McKinley AJ, Farrington SM, Curtis LJ, Wyllie AH, Zheng S, Willson JKV, Markowitz SD, Morin P, Kinzler KW, Vogelstein B, Dunlop MG (1996) APC mutations in colorectal tumors with mismatch repair deficiency. Proc Natl Acad Sci, USA 93:9049-9054
102. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX2). Cell 87:803-809.
103. 103. Dudley ME, Sundberg JP, Roopenian DC (1996) Frequency and histological appearance of adenomas in multiple intestinal neoplasia mice are unaffected by severe combined immunodeficiency (scid) mutation. Int J Cancer 65:249-253
104. 104. Taconic Farms I (1996) Immunodeficient rodents opening new doors for investigators. Res Animal Rev 1:1-8
105. 105. Tsujii M, DuBois RN (1995) Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83:493-501
106. 106. Shiff SJ, Koutsos MI, Qiao L, Rigas B (1996) Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis. Exp Cell Res 222:179-188
107. 107. Smith WL, Marnett LJ (1991) Prostaglandin endoperoxide synthase: structure and catalysis. Biochim Biophys Acta 1083:1-17
108. 109. Fisher E, Scambler P (1994) Human haploinsufficiency -one for sorrow, two for joy. Nature Genet 7:5-7
109. Min and Mom1 in intestinal neoplasia in mice. Ph.D. thesis, University of Wisconsin-Madison.
110. 111. Leapman SB, Deutsch AA, Grand RJ, Folkman J (1974) Transplantation of fetal intestine: survival and function in a subcutaneous location in adult animals. Ann Surg 179:109-114
111. 112. Di Marco E, Pierce JH, Fleming TP, Kraus MH, Molloy CJ, Aaronson SA, Di Fiore PP (1989) Autocrine interaction between TGFα and the EGF-receptor: quantitative requirements for induction of the malignant phenotype. Oncogene 4:831-838
112. 113. Rosenthal A, Lindquist PB, Bringman TS, Goeddel DV, Derynck R (1986) Expression in rat fibroblasts of a human transforming growth factor-α cDNA results in transformation. Cell 46:301-309
113. 114. Matsui Y, Halter SA, Holt JT, Hogan BLM, Coffey RJ (1990) Development of mammary hyperplasia and neoplasia in MMTV-TGFα transgenic mice. Cell 61:1147-1155
114. 115. Sandgren EP, Luetteke NC, Palmiter RD, Brinster RL, Lee DC (1990) Overexpression of TGFα in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell 61:1121-1135
115. 116. Sandgren EP, Schroeder JA, Qui TH, Palmiter RD, Brinster RL, Lee DC (1995) Inhibition of mammary gland involution is associated with transforming growth factor a but not c-myc-induced tumorigenesis in transgenic mice. Cancer Res 55:3915-3927
116. 117. Gordon JI (1989) Intestinal epithelial differentiation: new insights from chimeric and transgenic mice. J Cell Biol 108:1187-1194
117. 118. Hereford LM, Hartwell LH (1974) Sequential gene function in the initiation of Saccharomyces cerevisiae DNA synthesis. J Mol Biol 84:4454-61.